Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is C-Reactive Protein  [Clear All Filters]
Journal Article
Raffield LM, Iyengar AK, Wang B, et al. "Allelic Heterogeneity at the CRP Locus Identified by Whole-Genome Sequencing in Multi-ancestry Cohorts." Am J Hum Genet. 2020;106(1):112-120.
Folsom AR, Chambless LE, Ballantyne CM, et al. "An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study." Arch Intern Med. 2006;166(13):1368-73.
Folsom AR, Golden S H, Boland LL. "Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women." Eur J Epidemiol. 2005;20(12):1015-22.
Schick UM, Auer PL, Bis JC, et al. "Association of exome sequences with plasma C-reactive protein levels in >9000 participants." Hum Mol Genet. 2015;24(2):559-71.
Prizment AE, Anderson KE, Visvanathan K. "Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study." Cancer Epidemiol Biomarkers Prev. 2011;20(2):297-307.
Walker KA, B Windham G, Brown CH, et al. "The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study." J Alzheimers Dis. 2018;66(3):1041-1052.
Rebholz CM, Astor BC, Grams ME, et al. "Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study." Nephrol Dial Transplant. 2015;30(1):77-83.
Appiah D, Schreiner PJ, Maclehose RF. "Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb Vasc Biol. 2015;35(12):2700-6.
Folsom AR, Desvarieux M, Nieto JF, Boland LL, Ballantyne CM. "B vitamin status and inflammatory markers." Atherosclerosis. 2003;169(1):169-74.
Agarwala A, Virani S, Couper DJ, et al. "Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study." Atherosclerosis. 2016;253:156-163.
Cushman M, O'Meara ES, Heckbert SR, Zakai NA, Rosamond WD. "Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology." Thromb Res. 2016;144:127-32.
Sinner MF, Stepas KA, Moser CB, et al. "B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies." Europace. 2014;16(10):1426-33.
Saunders JT, Nambi V, de Lemos JA, et al. "Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study." Circulation. 2011;123(13):1367-76.
"Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis." Lancet Diabetes Endocrinol. 2015;3(4):243-53.
Yang EY, Nambi V, Tang Z, et al. "Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study." J Am Coll Cardiol. 2009;54(25):2388-95.
Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N. "Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)." Am J Med. 2002;113(8):636-42.
Folsom AR, Aleksic N, Catellier D, Juneja HS. "C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study." Am Heart J. 2002;144(2):233-8.
Folsom AR, Lutsey PL, Astor BC. "C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort." Thromb Haemost. 2009;102(4):615-9.
Kaptoge S, Di Angelantonio E, Pennells L, et al. "C-reactive protein, fibrinogen, and cardiovascular disease prediction." N Engl J Med. 2012;367(14):1310-20.
Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D. "Cumulative life course and adult socioeconomic status and markers of inflammation in adulthood." J Epidemiol Community Health. 2008;62(6):484-91.
Silvestre OM, Nadruz W, Roca GQuerejeta, et al. "Declining Lung Function and Cardiovascular Risk: The ARIC Study." J Am Coll Cardiol. 2018;72(10):1109-1122.
Kocarnik JM, Richard M, Graff M, et al. "Discovery, fine-mapping, and conditional analyses of genetic variants associated with C-reactive protein in multiethnic populations using the Metabochip in the Population Architecture using Genomics and Epidemiology (PAGE) study." Hum Mol Genet. 2018;27(16):2940-2953.
Ligthart S, Marzi C, Aslibekyan S, et al. "DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases." Genome Biol. 2016;17(1):255.
Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D. "Early-life and adult socioeconomic status and inflammatory risk markers in adulthood." Eur J Epidemiol. 2007;22(1):55-66.
Whelton SP, Roy P, Astor BC, Zhang L, Hoogeveen RC, Ballantyne CM. "Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study." Am J Epidemiol. 2013;178(7):1076-84.
Ding N, Yang C, Ballew SH, et al. "Fibrosis and Inflammatory Markers and Long-Term Risk of Peripheral Artery Disease: The ARIC Study." Arterioscler Thromb Vasc Biol. 2020;40(9):2322-2331.
Ligthart S, Vaez A, Võsa U, et al. "Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders." Am J Hum Genet. 2018;103(5):691-706.
Di Angelantonio E, Gao P, Khan H, et al. "Glycated hemoglobin measurement and prediction of cardiovascular disease." JAMA. 2014;311(12):1225-33.
Sturgeon JD, Folsom AR, Longstreth WT, Shahar E, Rosamond WD. "Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort." Stroke. 2008;39(8):2268-73.
Ellis J, Lange EM, Li J, et al. "Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans." Hum Genet. 2014;133(8):985-95.
Nambi V, Hoogeveen RC, Chambless L, et al. "Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2009;40(2):376-81.
Ballantyne CM, Hoogeveen RC, Bang H, Coresh JJ, Folsom AR, Heiss G. "Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study." Circulation. 2004;109(7):837-42.
Ballantyne CM, Hoogeveen RC, Bang H, et al. "Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study." Arch Intern Med. 2005;165(21):2479-84.
Folsom AR, Lutsey PL, Heckbert SR, et al. "Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism." J Thromb Haemost. 2018;16(10):1964-1972.
Kang S, Cai J. "Marginal additive hazards model for case-cohort studies with multiple disease outcomes: an application to the Atherosclerosis Risk in Communities (ARIC) study." Biostatistics. 2013;14(1):28-41.
Dehghan A, Dupuis J, Barbalic M, et al. "Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels." Circulation. 2011;123(7):731-8.
Walker KA, Walston J, Gottesman RF, Kucharska-Newton AMaria, Palta P. "Midlife Systemic Inflammation Is Associated With Frailty in Later Life: The ARIC Study." J Gerontol A Biol Sci Med Sci. 2019;74(3):343-349.
Walker KA, Power MC, Hoogeveen RC, et al. "Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The Atherosclerosis Risk in Communities Study." Stroke. 2017;48(12):3196-3202.
Evans DM, Brion MJo A, Paternoster L, et al. "Mining the human phenome using allelic scores that index biological intermediates." PLoS Genet. 2013;9(10):e1003919.
Kocarnik JM, Pendergrass SA, Carty CL, et al. "Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study." Circ Cardiovasc Genet. 2014;7(2):178-88.
Singer RE, Moss K, Kim SJ, Beck JD. "Oxidative Stress and IgG Antibody Modify Periodontitis-CRP Association." J Dent Res. 2015;94(12):1698-705.
Beck JD, Moss KL, Morelli T. "Periodontal profile class is associated with prevalent diabetes, coronary heart disease, stroke, and systemic markers of C-reactive protein and interleukin-6." J Periodontol. 2018;89(2):157-165.
Prizment AE, Folsom AR, Dreyfus J, et al. "Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study." Cancer Causes Control. 2013;24(12):2077-87.
Ligthart S, de Vries PS, Uitterlinden AG, Hofman A, Franco OH, Chasman DI. "Pleiotropy among common genetic loci identified for cardiometabolic disorders and C-reactive protein." PLoS One. 2015;10(3):e0118859.
Morrison AC, Huang Z, Yu B, et al. "Practical Approaches for Whole-Genome Sequence Analysis of Heart- and Blood-Related Traits." Am J Hum Genet. 2017;100(2):205-215.
Agarwal SK, Chambless LE, Ballantyne CM, et al. "Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study." Circ Heart Fail. 2012;5(4):422-9.
Virani SS, Nambi V, Hoogeveen RC, et al. "Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study." Eur Heart J. 2011;32(4):459-68.
Slade GD, Ghezzi EM, Heiss G, Beck JD, Riche E. "Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study." Arch Intern Med. 2003;163(10):1172-9.
Beck JD. "Relationships among clinical measures of periodontal disease and their associations with systemic markers." Ann Periodontol. 2002;7(1):79-89.
Parrinello CM, Matsushita K, Woodward M, Wagenknecht LE, Coresh JJ. "Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study." Diabetes Obes Metab. 2016;18(9):899-906.
Roca GQuerejeta, Redline S, Claggett B, Bello N, Ballantyne CM, Solomon SD. "Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study." Circulation. 2015;132(14):1329-37.
Parrinello CM, Lutsey PL, Ballantyne CM, Folsom AR, Pankow JS. "Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality." Am Heart J. 2015;170(2):380-9.
Selvin E, Halushka MK, Rawlings AM, Hoogeveen RC, Ballantyne CM, Coresh JJ. "sRAGE and risk of diabetes, cardiovascular disease, and death." Diabetes. 2013;62(6):2116-21.
Rifai MAl, Schneider ALC, Alonso A, et al. "sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study." J Diabetes Complications. 2015;29(2):180-5.
Walker KA, Gottesman RF, Wu A, et al. "Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study." Neurology. 2019;92(11):e1256-e1267.
Oluleye OW, Folsom AR, Nambi V, Lutsey PL. "Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality." Ann Epidemiol. 2013;23(2):66-73.
Hermida J, Norby FL, Montes R, Matsushita K, Astor BC. "Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study)." Am J Cardiol. 2012;109(1):95-9.
Bekwelem W, Lutsey PL, Loehr LR, et al. "White blood cell count, C-reactive protein, and incident heart failure in the Atherosclerosis Risk in Communities (ARIC) Study." Ann Epidemiol. 2011;21(10):739-48.